PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26349001-4	2015	RESULTS: DS injections prevented thrombus formation and decreased P-selectin expression after 3 days of the injury.	Dermatan Sulfate	9-11	selectin, platelet	Mus musculus	66-76	
21676168-4	2011	OBJECTIVES AND METHODS: The aim of the present study was to determine the capacity of dermatan sulfates to inhibit P-selectin and to test their potential to affect thrombosis, inflammation and metastasis in respective experimental mouse models.	Dermatan Sulfate	86-103	selectin, platelet	Mus musculus	115-125	
21676168-5	2011	RESULTS: Two dermatan sulfates isolated from the ascidians Styela plicata and Phallusia nigra, composed of the same disaccharide core structure (IdoA2-GalNAc)(n) , but sulfated at carbon 4 or 6 of the GalNAc, respectively, have opposed heparin cofactor II (HCII) activities and are potent inhibitors of P-selectin.	Dermatan Sulfate	13-30	selectin, platelet	Mus musculus	303-313	
21676168-8	2011	The analysis of arterial thrombi demonstrated markedly reduced platelet deposition after dermatan sulfate treatment, suggesting that the glycosaminoglycan inhibited P-selectin and thereby the binding of activated platelets during thrombus formation.	Dermatan Sulfate	89-105	selectin, platelet	Mus musculus	165-175	
21250866-8	2011	Treatment with DS inhibited thrombosis, decreased CD45(+) cell accumulation and P-selectin expression at the site of injury, and reduced the neointimal area by 56%.	Dermatan Sulfate	15-17	selectin, platelet	Mus musculus	80-90